Publications by authors named "Alex Herrera"

Claim this Profile
E
Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.
Franck Morschhauser, Gilles Salles, Laurie H Sehn, Alex F Herrera, Jonathan W Friedberg

J Clin Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR Analysis.
Kalyan V Nadiminti, Kwang W Ahn, Jinalben Patel, Qinghua Lian, Evandro Bezerra, Alex F Herrera

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world infectious complications of CD3/CD20 bispecific antibodies in relapsed/refractory non-Hodgkin lymphoma.
Annie Xiao, Lu Chen, Stacy Pak, Brian Lee, Matthew Mei, Alex Herrera

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study.
Alex F Herrera, Stephen M Ansell, Pier Luigi Zinzani, John Radford, Kami Maddocks

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.
Franck Morschhauser, Gilles Salles, Laurie H Sehn, Alex F Herrera, Jonathan W Friedberg

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetration.
Lei Gao, Avyakta Kallam, Geoffrey Shouse, John H Baird, Stacy Pak, Alex F Herrera

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma.
Sanjal H Desai, Alison J Moskowitz, Reid W Merryman, Harsh R Shah, Levi D Pederson, Alex F Herrera

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (CAPITAL).
Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin, Antonio Salar, Sabela Bobillo, Alex F Herrera

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of clonal haematopoiesis and diabetes with outcomes after autologous haematopoietic cell transplantation.
Rusha Bhandari, June-Wha Rhee, Sitong Chen, Raju Pillai, Alysia Bosworth, Alex F Herrera

Diabetes Obes Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASTCT Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma.
Sairah Ahmed, Ambuj Kumar, Paul Carpenter, Alex Herrera, Kara Kelly

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 Trial.
Caron A Jacobson, Jason R Westin, David B Miklos, Alex F Herrera, Jerome Ritz

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II study.
Swetha Kambhampati Thiruvengadam, Leslie L Popplewell, Alex F Herrera, Matthew Mei, Liana Nikolaenko

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti-PD-1-refractory Hodgkin lymphoma.
Philippe Armand, Pier Luigi Zinzani, John Timmerman, Nathalie A Johnson, David Lavie, Alex F Herrera

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis.
Nausheen Ahmed, Swetha Kambhampati Thiruvengadam, Mehdi Hamadani, Zhen-Huan Hu, Natalie Grover, Alex F Herrera

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis.
Swetha Kambhampati Thiruvengadam, Kwang Woo Ahn, Jinalben Patel, Qinghua Lian, Mark Hertzberg, Alex F Herrera

Am J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis.
Jordan Gauthier, Kwang W Ahn, Jinalben Patel, Qinghua Lian, Sherif Badawy, Alex F Herrera

Am J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with CAR-T therapy in relapsed and refractory follicular lymphoma.
Nicolás Triantafilo, Arnab Chowdhury, Swetha Thiruvengadam, Alex F Herrera, Leslie Popplewell

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma.
Paolo Lopedote, Geoffrey Shouse, Lu Chen, Diane Lynne Smith, Jessica Ford, Alex F Herrera

Leuk Lymphoma· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.
Sarah C Rutherford, Hongli Li, Alex F Herrera, Michael LeBlanc, Sairah Ahmed

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis and risk of nonmyeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantation.
June-Wha Rhee, Sitong Chen, Raju Pillai, Alysia Bosworth, Artem Oganesyan, Alex F Herrera

J Natl Cancer Inst· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS.
Nasheed M Hossain, Kwang Woo Ahn, Jinalben Patel, Qinghua Lian, Muhammad Bilal Abid, Alex F Herrera

Br J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifaceted cfDNA profiling in mantle cell lymphoma.
Brian J Sworder, Alex F Herrera

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis.
Miguel-Angel Perales, Farrukh T Awan, Ariane Boumendil, Jinalben Patel, Luca Castagna, Alex F Herrera

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Working towards harmonization of clinical trial reporting in Hodgkin lymphoma.
Carsten Kobe, Philippe Armand, Sven Borchmann, Graham P Collins, Anne-Segolene Cottereau, Alex F Herrera

Hemasphere· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I trial.
Geoffrey Shouse, Canping Chen, Alexandra Muir, Leslie Popplewell, Tanya Siddiqi, Alex F Herrera

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis